International Immunology Advance Access originally published online on April 29, 2008
International Immunology 2008 20(6):791-800; doi:10.1093/intimm/dxn037
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
1 Department of Immunology and Medical Zoology
2 Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan
3 Collaborative Development of Innovation Seeds, Japan Science and Technology Corporation, Saitama 332-0012, Japan
4 Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan
5 Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan
Correspondence to: K. Nakanishi; E-mail: nakaken{at}hyo-med.ac.jp
Systemic administration of IL-18 induces polyclonal IgE responses by causing NKT cells to express CD40 ligand and to produce IL-4. Administration of IL-33 also induces IgE response, although the mechanism underlying IgE response is unclear. Here, we compared the effects of IL-18 and IL-33 on bone marrow-derived mast cells and basophils as well as non-polarized and Th2-polarized CD4+ T cells in vitro. Basophils, comprising IL-18R
+ cells (14.2%) and IL-33R
+ cells (34.6%), and mast cells, comprising IL-18R
+ cells (2.0%) and IL-33R
+ cells (95.6%), produce IL-4, IL-6, IL-13, granulocyte macrophage colony-stimulating factor (GM-CSF) and chemokines (RANTES, MIP-1
, MIP-1β and MCP-1), upon stimulation with IL-18 and/or IL-33 in the presence of IL-3. Only basophils strongly produce IL-4. Furthermore, compared with mast cells, basophils produce larger amounts of the above cytokines and chemokines in response to IL-33. Level of IL-33Rβ-mRNA expression in basophils is higher than that in mast cells. Effect of IL-33 is dependent on ST2 binding, and its signal is transduced via MyD88 in vitro. We also found that IL-2 plus IL-18 or IL-33 alone stimulates non-polarized or Th2-polarized CD4+ T cells to produce IL-4 and IL-13 or IL-5 and IL-13, respectively. We finally showed that administration of IL-33 into mice ST2/MyD88 dependently induces airway hyperresponsiveness (AHR) and goblet cell hyperplasia by induction of IL-4, IL-5 and IL-13 in the lungs. Furthermore, same treatment of RAG-2–/– mice, lacking T and B cells, more strikingly induced AHR with marked goblet cell hyperplasia and eosinophilic infiltration in the lungs. Thus, IL-33 induces asthma-like symptom entirely independent of acquired immune system.
Keywords: basophils, IL-33, innate immunity, ST2, Th2 cytokines
* These authors contributed equally to this study.
Transmitting editor: T. Hamaoka
Received 6 February 2008, accepted 26 March 2008.
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Int. Immunol.:
- IN THIS ISSUE
Int. Immunol. 2008 20: NP.[Extract] [Full Text]
This article has been cited by other articles:
![]() |
F. D. Finkelman, S. P. Hogan, G. K. K. Hershey, M. E. Rothenberg, and M. Wills-Karp Importance of Cytokines in Murine Allergic Airway Disease and Human Asthma J. Immunol., February 15, 2010; 184(4): 1663 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Rankin, J. B. Mumm, E. Murphy, S. Turner, N. Yu, T. K. McClanahan, P. A. Bourne, R. H. Pierce, R. Kastelein, and S. Pflanz IL-33 Induces IL-13-Dependent Cutaneous Fibrosis J. Immunol., February 1, 2010; 184(3): 1526 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G E J Murphy, D Xu, F Y Liew, and I B McInnes Role of interleukin 33 in human immunopathology Ann Rheum Dis, January 1, 2010; 69(Suppl_1): i43 - i47. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurowska-Stolarska, B. Stolarski, P. Kewin, G. Murphy, C. J. Corrigan, S. Ying, N. Pitman, A. Mirchandani, B. Rana, N. van Rooijen, et al. IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation J. Immunol., November 15, 2009; 183(10): 6469 - 6477. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Knol and B. F. Gibbs Editorial: Basophil survival and immunomodulatory function are uniquely regulated by a novel MyD88-dependent pathway J. Leukoc. Biol., October 1, 2009; 86(4): 753 - 755. [Full Text] [PDF] |
||||
![]() |
E. Schneider, A.-F. Petit-Bertron, R. Bricard, M. Levasseur, A. Ramadan, J.-P. Girard, A. Herbelin, and M. Dy IL-33 Activates Unprimed Murine Basophils Directly In Vitro and Induces Their In Vivo Expansion Indirectly by Promoting Hematopoietic Growth Factor Production J. Immunol., September 15, 2009; 183(6): 3591 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cayrol and J.-P. Girard The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 PNAS, June 2, 2009; 106(22): 9021 - 9026. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kearley, K. F. Buckland, S. A. Mathie, and C. M. Lloyd Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent upon Disruption of the T1/ST2-IL-33 Pathway Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 772 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pecaric-Petkovic, S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33 Blood, February 12, 2009; 113(7): 1526 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wiener, P. Pocza, M. Racz, G. Nagy, G. Tolgyesi, V. Molnar, J. Jaeger, E. Buzas, E. Gorbe, Z. Papp, et al. IL-18 induces a marked gene expression profile change and increased Ccl1 (I-309) production in mouse mucosal mast cell homologs Int. Immunol., December 1, 2008; 20(12): 1565 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurowska-Stolarska, P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, A. N. J. McKenzie, et al. IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4 J. Immunol., October 1, 2008; 181(7): 4780 - 4790. [Abstract] [Full Text] [PDF] |
||||






